1. Home
  2. Analysis
  3. Naproxen
  4. Dramamine

Naproxen and Dramamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naproxen and Dramamine. Common interactions include chronic kidney disease among females and convulsion among males.

The phase IV clinical study analyzes what interactions people who take Naproxen and Dramamine have. It is created by eHealthMe based on reports of 6 people who take Naproxen and Dramamine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

6 people who take Naproxen and Dramamine together, and have interactions are studied.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 57,583 Naproxen users for its effectiveness, alternative drugs and more.

What is Dramamine?

Dramamine has active ingredients of dimenhydrinate. It is often used in motion sickness. eHealthMe is studying from 1,223 Dramamine users for its effectiveness, alternative drugs and more.

Number of Naproxen and Dramamine reports submitted per year:

Naproxen and Dramamine drug interactions.

Common Naproxen and Dramamine drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease
  3. Renal failure

male:

  1. Convulsion
  2. Dysphagia
  3. Decreased appetite
  4. Depression
  5. Drug intolerance
  6. Dry mouth
  7. Dysstasia
  8. Euphoric mood
  9. Fall
  10. Feeling jittery

Common Naproxen and Dramamine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Convulsion
  2. Dysphagia
  3. Sinus disorder
  4. Subcutaneous emphysema
  5. Respiratory failure
  6. Status epilepticus

50-59:

  1. Decreased appetite
  2. Depression
  3. Drug intolerance
  4. Dry mouth
  5. Dysstasia
  6. Euphoric mood
  7. Fall
  8. Feeling jittery
  9. Gastric perforation
  10. Haemorrhage

60+:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease
  3. Renal failure

* Approximation only. Some reports may have incomplete information.

Do you take Naproxen and Dramamine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Naproxen and Dramamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Naproxen side effects:

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Dramamine side effects:

Browse all side effects of Dramamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Naproxen interactions:

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Dramamine interactions:

Browse all interactions between Dramamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naproxen and dimenhydrinate (the active ingredients of Naproxen and Dramamine, respectively), and Naproxen and Dramamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Naproxen and Dramamine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.